2nd International
Brain Technology Conference

March 11-12, Hangar 11, Tel Aviv Port, Israel

Iris Shichor, PhD

Co-founder & CEO, SipNose

Iris Shichor

Dr. Shichor holds a Ph.D. from the Hebrew University of Jerusalem. Her background includes strong expertise in biochemistry and physiology, neuroscience and drug delivery systems. Before co-founding SipNose, Dr. Shichor was VP R&D at ClearFarma, and a senior scientist and project leader at NanoCyte Ltd. where she developed an innovative platform technology for transdermal delivery. Her previous experience includes a post-doctoral fellowship in the laboratory of Institute Professor Robert S. Langer at MIT, in the field of drug delivery. Dr. Shichor brings her experience in leading research and development programs and managing product development projects from concept to product.